Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities
复制标题
DOI：
10.1197/jamia.m2177
复制
发表时间：
2007-05-01
影响因子：
6.4
通讯作者：
Schrag, Deborah
中科院分区：
文献类型：
--
作者：
Basch, Ethan;Artz, David;Schrag, Deborah
目前在癌症试验中监测毒性症状的机制依赖于复杂的基于纸张的过程。患者报告结局（PRO）的电子收集可能更有效和准确。创建了一个在线PRO平台，包括一个简单的数据输入界面，实时报告生成，以及一个警报系统，当患者自我报告严重毒性时，可以通过电子邮件向临床医生发送警报。涉及180名化疗患者的可行性评估表明，在16个月内每名患者最多40次随访诊所访视时（任何给定访视时85%的患者），患者和临床医生的接受度和满意度都很高（> 95%）。警报被用作延迟化疗治疗、剂量调整和时间安排变更的依据。这些结果表明，在线患者报告是化疗毒性症状监测的可行策略，并可提高安全性和护理满意度。正在进行的多中心研究将评估这种方法对临床和管理结果的影响。
The current mechanism for monitoring toxicity symptoms in cancer trials depends on a complex paper-based process. Electronic collection of Patient-reported outcomes (PROs) may be more efficient and accurate. An online PRO platform was created including a simple data entry interface, real-time report generation, and an alert system to e-mail clinicians when patients self-report serious toxicities. Feasibility assessment involving 180 chemotherapy patients demonstrated high levels of use at up to 40 follow-up clinic visits per patient over 16 months (85% of patients at any given visit), with high levels of patient and clinician acceptance and satisfaction (> 95%). Alerts were used as the basis for delayed chemotherapy treatments, dose modifications, and scheduling changes. These results demonstrate that online patient-reporting is a feasible strategy for chemotherapy toxicity symptom monitoring, and may improve safety and satisfaction with care. Ongoing multi-center research will evaluate the impact of this approach on clinical and administrative outcomes.